Search research articles
Contact Us
Filters
Showing results (71-80 of 134) with videos related to
Page
of 14
Sort By:
Cancer Immunology, Immunotherapy : CII
|
June 15, 2017
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
Sapna P Patel, Dae Won Kim, Roland L Bassett, et al.
Oncotarget
|
October 28, 2015
Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma
David S Hong, Razelle Kurzrock, Gerald S Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma
Grant A McArthur, Igor Puzanov, Ravi Amaravadi, et al.
The New England Journal of Medicine
|
September 8, 2010
Inhibition of mutated, activated BRAF in metastatic melanoma
Keith T Flaherty, Igor Puzanov, Kevin B Kim, et al.
Journal of Cutaneous Pathology
|
July 20, 2012
BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma
Jinhyun Kim, Alexander J Lazar, Michael A Davies, et al.
Melanoma Research
|
July 16, 2008
Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment
Cindy S Hwang, Victor G Prieto, Abdul H Diwan, et al.
Annals of Surgical Oncology
|
August 15, 2018
Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery
Stanley P Leong, Max Wu, Ying Lu, et al.
Annals of Surgical Oncology
|
February 27, 2019
Correction to: Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery
Stanley P Leong, Max Wu, Ying Lu, et al.
Melanoma Research
|
April 19, 2014
Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma
Anas Alrwas, Nicholas E Papadopoulos, Suzanne Cain, et al.
Cancer
|
September 14, 2012
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P Patel, Alexander J Lazar, Nicholas E Papadopoulos, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 134) with videos related to
Sort By:
Page
of 14
Cancer Immunology, Immunotherapy : CII
|
June 15, 2017
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
Sapna P Patel, Dae Won Kim, Roland L Bassett, et al.
Oncotarget
|
October 28, 2015
Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma
David S Hong, Razelle Kurzrock, Gerald S Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma
Grant A McArthur, Igor Puzanov, Ravi Amaravadi, et al.
The New England Journal of Medicine
|
September 8, 2010
Inhibition of mutated, activated BRAF in metastatic melanoma
Keith T Flaherty, Igor Puzanov, Kevin B Kim, et al.
Journal of Cutaneous Pathology
|
July 20, 2012
BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma
Jinhyun Kim, Alexander J Lazar, Michael A Davies, et al.
Melanoma Research
|
July 16, 2008
Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment
Cindy S Hwang, Victor G Prieto, Abdul H Diwan, et al.
Annals of Surgical Oncology
|
August 15, 2018
Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery
Stanley P Leong, Max Wu, Ying Lu, et al.
Annals of Surgical Oncology
|
February 27, 2019
Correction to: Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery
Stanley P Leong, Max Wu, Ying Lu, et al.
Melanoma Research
|
April 19, 2014
Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma
Anas Alrwas, Nicholas E Papadopoulos, Suzanne Cain, et al.
Cancer
|
September 14, 2012
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P Patel, Alexander J Lazar, Nicholas E Papadopoulos, et al.
Page
of 14